Similar articles for PMID: 16521363

Year	Number of Results
1983	1
1988	2
1989	2
1990	4
1991	2
1992	1
1994	4
1995	3
1996	2
1997	5
1998	3
1999	2
2000	7
2001	3
2002	6
2003	9
2004	10
2005	4
2006	11
2007	9
2008	13
2009	7
2010	11
2011	11
2012	16
2013	18
2014	20
2015	9
2016	12
2017	12
2018	26
2019	37
2020	29
2021	38
2022	27
2023	9
2024	0

1

Regulating medicines in Europe: the European Medicines Agency, marketing authorisation, transparency and pharmacovigilance.

Permanand G, Mossialos E, McKee M. Permanand G, et al. Clin Med (Lond). 2006 Jan-Feb;6(1):87-90. doi: 10.7861/clinmedicine.6-1-87. Clin Med (Lond). 2006. PMID: 16521363 Free PMC article.

2

Top adviser at the European Medicines Agency quits suddenly.

Benkimoun P. Benkimoun P. BMJ. 2012 Apr 11;344:e2641. doi: 10.1136/bmj.e2641. BMJ. 2012. PMID: 22496308 No abstract available.

3

Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.

Borg JJ, Aislaitner G, Pirozynski M, Mifsud S. Borg JJ, et al. Drug Saf. 2011 Mar 1;34(3):187-97. doi: 10.2165/11586620-000000000-00000. Drug Saf. 2011. PMID: 21332243 Review.

4

Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.

Tomić S, Sucić AF, Martinac AI. Tomić S, et al. Regul Toxicol Pharmacol. 2010 Jul-Aug;57(2-3):325-32. doi: 10.1016/j.yrtph.2010.04.001. Epub 2010 Apr 10. Regul Toxicol Pharmacol. 2010. PMID: 20385190

5

The European Medicines Agency: an overview of its mission, responsibilities, and recent initiatives in cancer drug regulation.

Pignatti F, Gravanis I, Herold R, Vamvakas S, Jonsson B, Marty M. Pignatti F, et al. Clin Cancer Res. 2011 Aug 15;17(16):5220-5. doi: 10.1158/1078-0432.CCR-11-0623. Clin Cancer Res. 2011. PMID: 21844037

6

[The network of official medicines control laboratories].

Buchheit KH, Wanko R. Buchheit KH, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Oct;57(10):1139-44. doi: 10.1007/s00103-014-2025-1. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014. PMID: 25192832 German.

7

European Medicines Agency review of post-authorisation studies with implications for the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.

Blake KV, Prilla S, Accadebled S, Guimier M, Biscaro M, Persson I, Arlett P, Blackburn S, Fitt H. Blake KV, et al. Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1021-9. doi: 10.1002/pds.2209. Pharmacoepidemiol Drug Saf. 2011. PMID: 22039593

8

The licensing of medicines in the UK.

[No authors listed] [No authors listed] Drug Ther Bull. 2009 Apr;47(4):45-8. doi: 10.1136/dtb.2009.03.0012. Drug Ther Bull. 2009. PMID: 19357299

9

[The use of nanotechnology in medicinal products in the light of European Union law].

Jurewicz M. Jurewicz M. Pol Merkur Lekarski. 2014 Dec;37(222):369-72. Pol Merkur Lekarski. 2014. PMID: 25715580 Review. Polish.

10

[Biosimilars: regulatory status for approval].

Herrero Ambrosio A. Herrero Ambrosio A. Farm Hosp. 2010 Mar;34 Suppl 1:16-8. doi: 10.1016/S1130-6343(10)70004-0. Farm Hosp. 2010. PMID: 20920853 Free article. Review. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

348 results

Results by year